These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose in predicting treatment response in unresectable hepatocellular carcinoma patients treated with external beam radiotherapy. Kim JW; Seong J; Yun M; Lee IJ; Yoon HI; Cho HJ; Han KH Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1172-8. PubMed ID: 21570203 [TBL] [Abstract][Full Text] [Related]
24. Value of positron emission tomography with [F-18]fluorodeoxyglucose in patients with colorectal liver metastases: a prospective study. Ruers TJ; Langenhoff BS; Neeleman N; Jager GJ; Strijk S; Wobbes T; Corstens FH; Oyen WJ J Clin Oncol; 2002 Jan; 20(2):388-95. PubMed ID: 11786565 [TBL] [Abstract][Full Text] [Related]
25. Increased accumulation of 2-deoxy-2-[18F]Fluoro-D-glucose in liver metastases from colon carcinoma. Yonekura Y; Benua RS; Brill AB; Som P; Yeh SD; Kemeny NE; Fowler JS; MacGregor RR; Stamm R; Christman DR; Wolf AP J Nucl Med; 1982 Dec; 23(12):1133-7. PubMed ID: 6982967 [TBL] [Abstract][Full Text] [Related]
26. Interpretation variability of 18FDG-positron emission tomography studies in dementia. Hoffman JM; Hanson MW; Welsh KA; Earl N; Paine S; Delong D; Coleman RE Invest Radiol; 1996 Jun; 31(6):316-22. PubMed ID: 8761863 [TBL] [Abstract][Full Text] [Related]
27. Fluorine-18-fluorodeoxyglucose uptake of bone marrow on PET/CT can predict prognosis in patients with colorectal cancer after curative surgical resection. Lee JW; Baek MJ; Ahn TS; Lee SM Eur J Gastroenterol Hepatol; 2018 Feb; 30(2):187-194. PubMed ID: 29120905 [TBL] [Abstract][Full Text] [Related]
28. Positron emission tomography studies in patients with locally advanced and/or metastatic breast cancer: a method for early therapy evaluation? Jansson T; Westlin JE; Ahlström H; Lilja A; Långström B; Bergh J J Clin Oncol; 1995 Jun; 13(6):1470-7. PubMed ID: 7751894 [TBL] [Abstract][Full Text] [Related]
29. Efficacy of fluorine-18-deoxyglucose positron emission tomography in detecting tumor recurrence after local ablative therapy for liver metastases: a prospective study. Langenhoff BS; Oyen WJ; Jager GJ; Strijk SP; Wobbes T; Corstens FH; Ruers TJ J Clin Oncol; 2002 Nov; 20(22):4453-8. PubMed ID: 12431968 [TBL] [Abstract][Full Text] [Related]
30. [18FDG PET in the management of malignant lymphoma]. Cui RX; Zhou Q Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Dec; 25(6):645-9. PubMed ID: 14714303 [TBL] [Abstract][Full Text] [Related]
31. (18)F-fluorodeoxyglucose positron emission tomography/computed tomography and magnetic resonance imaging in patients with liver metastases from uveal melanoma: results from a pilot study. Orcurto V; Denys A; Voelter V; Schalenbourg A; Schnyder P; Zografos L; Leyvraz S; Delaloye AB; Prior JO Melanoma Res; 2012 Feb; 22(1):63-9. PubMed ID: 22027909 [TBL] [Abstract][Full Text] [Related]
32. Prediction of tumor biological characteristics in different colorectal cancer liver metastasis animal models using Xu HL; Li M; Zhang RJ; Jiang HJ; Zhang MY; Li X; Wang YQ; Pan WB Hepatobiliary Pancreat Dis Int; 2018 Apr; 17(2):140-148. PubMed ID: 29571649 [TBL] [Abstract][Full Text] [Related]
33. Fluorine-18 fluorodeoxyglucose positron emission tomography in the differential diagnosis of pancreatic carcinoma: a report of 106 cases. Zimny M; Bares R; Fass J; Adam G; Cremerius U; Dohmen B; Klever P; Sabri O; Schumpelick V; Buell U Eur J Nucl Med; 1997 Jun; 24(6):678-82. PubMed ID: 9169578 [TBL] [Abstract][Full Text] [Related]
34. Positron emission tomography of patients with head and neck carcinoma before and after high dose irradiation. Greven KM; Williams DW; Keyes JW; McGuirt WF; Watson NE; Randall ME; Raben M; Geisinger KR; Cappellari JO Cancer; 1994 Aug; 74(4):1355-9. PubMed ID: 8055460 [TBL] [Abstract][Full Text] [Related]
35. Imaging allergen-invoked airway inflammation in atopic asthma with [18F]-fluorodeoxyglucose and positron emission tomography. Taylor IK; Hill AA; Hayes M; Rhodes CG; O'Shaughnessy KM; O'Connor BJ; Jones HA; Hughes JM; Jones T; Pride NB; Fuller RW Lancet; 1996 Apr; 347(9006):937-40. PubMed ID: 8598758 [TBL] [Abstract][Full Text] [Related]
36. Evaluation of metabolic characteristics and viability of lipiodolized hepatocellular carcinomas using 18F-FDG PET/CT. Kim HO; Kim JS; Shin YM; Ryu JS; Lee YS; Lee SG J Nucl Med; 2010 Dec; 51(12):1849-56. PubMed ID: 21098794 [TBL] [Abstract][Full Text] [Related]
37. PET 2-fluoro-2-deoxyglucose uptake in rat prostate adenocarcinoma during chemotherapy with gemcitabine. Haberkorn U; Bellemann ME; Altmann A; Gerlach L; Morr I; Oberdorfer F; Brix G; Doll J; Blatter J; van Kaick G J Nucl Med; 1997 Aug; 38(8):1215-21. PubMed ID: 9255154 [TBL] [Abstract][Full Text] [Related]
38. [Assessment of 18FDG PET for diagnosis of pancreatic tumors]. Granov AM; Tiutin LA; Ryzhkova DV; Kostenikov NA; Fadeev NP; Savello VE; Pavlovskiĭ AV; Tlostanova MS; Efimenko AV; Stanzhevskiĭ AA Vestn Rentgenol Radiol; 2002; (2):18-22. PubMed ID: 12216484 [TBL] [Abstract][Full Text] [Related]
39. 18FDG uptake in oesophageal adenocarcinoma: linking biology and outcome. Westerterp M; Sloof GW; Hoekstra OS; Ten Kate FJ; Meijer GA; Reitsma JB; Boellaard R; van Lanschot JJ; Molthoff CF J Cancer Res Clin Oncol; 2008 Feb; 134(2):227-36. PubMed ID: 17653575 [TBL] [Abstract][Full Text] [Related]
40. Evaluation of preoperative chemotherapy using PET with fluorine-18-fluorodeoxyglucose in breast cancer. Bassa P; Kim EE; Inoue T; Wong FC; Korkmaz M; Yang DJ; Wong WH; Hicks KW; Buzdar AU; Podoloff DA J Nucl Med; 1996 Jun; 37(6):931-8. PubMed ID: 8683314 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]